Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 169.5 | 142.8 | 88.1 | 80.5 |
| Revenue growth | 18.7% | 62.2% | 9.5% | |
| Cost of goods sold | 62.7 | 53.7 | 32.4 | 32.0 |
| Gross profit | 106.8 | 89.1 | 55.7 | 48.5 |
| Gross margin | 63.0% | 62.4% | 63.2% | 60.2% |
| Sales and marketing | 49.9 | 27.7 | 9.9 | 27.2 |
| Research and development | 13.7 | 11.0 | 6.7 | 4.1 |
| General and administrative | 58.5 | 60.7 | 33.4 | 15.9 |
| EBIT | -15.2 | -10.3 | 5.7 | 1.2 |
| EBIT margin | -9.0% | -7.2% | 6.4% | 1.5% |
| Pre-tax income | -20.6 | -13.7 | 3.0 | -1.5 |
| Income taxes | 6.4 | -0.2 | 4.7 | -2.8 |
| Tax rate | | 1.3% | 157.9% | 182.2% |
| Net income | -27.0 | -13.6 | -1.7 | 0.0 |
| Net margin | -15.9% | -9.5% | -1.9% | 0.0% |
| |
| Diluted EPS | ($0.33) | ($0.36) | ($0.06) | $0.00 |
| Shares outstanding (diluted) | 80.8 | 38.0 | 27.4 | 25.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|